PLPL (Plandai Biotechnology) EV-to-OCF: (As of Aug. 03, 2026)

Plandai Biotechnology  (OTCPK:PLPL) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Plandai Biotechnology's PE Ratio (TTM) for today is calculated as:

Plandai Biotechnology's share price for today is $1.0E-5.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Plandai Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Plandai Biotechnology EV-to-OCF Related Terms

The historical data trend for Plandai Biotechnology's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology EV-to-OCF Chart

Plandai Biotechnology Annual Data
	Trend	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
EV-to-OCF		Get a 7-Day Free Trial					-20.70	-18.37	-17.11	0.00	0.00

Plandai Biotechnology Semi-Annual Data
	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
EV-to-OCF	Get a 7-Day Free Trial											0.00	0.00	0.00	0.00	0.00

PLPL vs CRGH, TCRI, MAYX: EV-to-OCF Comparison

For the Specialty Business Services subindustry, Plandai Biotechnology's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Plandai Biotechnology EV-to-OCF vs Business Services Industry

For the Business Services industry and Industrials sector, Plandai Biotechnology's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Plandai Biotechnology's EV-to-OCF falls into.

Plandai Biotechnology EV-to-OCF Calculation

Plandai Biotechnology's EV-to-OCF for today is calculated as:

Plandai Biotechnology's current Enterprise Value is $0.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Plandai Biotechnology's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology Business Description